Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare genetic eye disease characterized by optic disk anomalies (bilateral colobomatous optic disks, retinal vessels arising from the peripheral optic disk) and macular atrophy. Peripapillary chorioretinal atrophy and chorioretinal and iris coloboma have also been described. Patients present with horizontal nystagmus and poor visual acuity.
Features include always present findings: Microphthalmia; and common findings: Retinal detachment, Buphthalmos, Corneal scarring, and Glaucoma. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 8 | Retinal detachment, Cataract, Nystagmus |
SIX6 function has not been fully characterized.
Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome is associated with mutations in the SIX6 gene on chromosome 14.
Genetic testing for SIX6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for colobomatous optic disc-macular atrophy-chorioretinopathy syndrome has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 4 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for colobomatous optic disc-macular atrophy-chorioretinopathy syndrome.
100 publications have been identified in PubMed for colobomatous optic disc-macular atrophy-chorioretinopathy syndrome. Kisho has analyzed 74 by research type. Research spans Review / Meta-Analysis (50%), Basic Science / Preclinical (16%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 37 |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 7:26 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about colobomatous optic disc-macular atrophy-chorioretinopathy syndrome
1 |
Macular atrophy |
Age of onset: at birth.
Laboratory research | 12 | 16% |
Disease patterns and progression | 11 | 15% |
Testing and diagnosis research | 6 | 8% |
Other research | 3 | 4% |
New treatment approaches | 3 | 4% |
Patient case studies | 2 | 3% |
Laich Y (2026). [PMID: 42217979](https://pubmed.ncbi.nlm.nih.gov/42217979/). *Handb Clin Neurol*. [Review / Meta-Analysis]
Alibrandi S (2026). [PMID: 42123608](https://pubmed.ncbi.nlm.nih.gov/42123608/). *Int J Mol Sci*. [Other]
Miura M (2026). [PMID: 42151388](https://pubmed.ncbi.nlm.nih.gov/42151388/). *Sci Rep*. [Other]
Chopra A (2026). [PMID: 41870099](https://pubmed.ncbi.nlm.nih.gov/41870099/). *Int Ophthalmol Clin*. [Review / Meta-Analysis]
Zhou HW (2025). [PMID: 40601510](https://pubmed.ncbi.nlm.nih.gov/40601510/). *Int Ophthalmol Clin*. [Review / Meta-Analysis]
Diaz A (2025). [PMID: 40736823](https://pubmed.ncbi.nlm.nih.gov/40736823/). *Adv Exp Med Biol*. [Review / Meta-Analysis]
Charbel Issa P (2025). [PMID: 39820891](https://pubmed.ncbi.nlm.nih.gov/39820891/). *Klin Monbl Augenheilkd*. [Review / Meta-Analysis]
Bammidi S (2025). [PMID: 40205682](https://pubmed.ncbi.nlm.nih.gov/40205682/). *Autophagy*. [Epidemiology / Natural History]
Butovsky O (2025). [PMID: 40324382](https://pubmed.ncbi.nlm.nih.gov/40324382/). *Immunity*. [Review / Meta-Analysis]
Anisetti B (2025). [PMID: 40497378](https://pubmed.ncbi.nlm.nih.gov/40497378/). *Neurol Neurochir Pol*. [Epidemiology / Natural History]